The Chemours Company (NYSE:CC – Get Free Report) has been assigned a consensus rating of “Hold” from the twelve research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $24.10.
A number of equities research analysts recently weighed in on the stock. Alembic Global Advisors restated an “overweight” rating and issued a $30.00 target price on shares of Chemours in a report on Wednesday, May 13th. UBS Group lifted their price target on Chemours from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Morgan Stanley boosted their price objective on Chemours from $17.00 to $21.00 and gave the stock an “equal weight” rating in a report on Monday, May 11th. Weiss Ratings reissued a “sell (d)” rating on shares of Chemours in a research note on Monday, April 20th. Finally, Zacks Research upgraded Chemours from a “strong sell” rating to a “hold” rating in a report on Friday, April 24th.
View Our Latest Stock Report on Chemours
Institutional Trading of Chemours
Chemours Stock Performance
CC opened at $20.12 on Thursday. Chemours has a 1-year low of $10.44 and a 1-year high of $28.67. The company has a market cap of $3.03 billion, a price-to-earnings ratio of -7.62 and a beta of 1.41. The company’s fifty day moving average price is $22.70 and its two-hundred day moving average price is $19.20. The company has a current ratio of 1.82, a quick ratio of 0.87 and a debt-to-equity ratio of 18.98.
Chemours (NYSE:CC – Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.10. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.40 billion. Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. The business’s revenue was up 1.0% on a year-over-year basis. During the same period last year, the company earned $0.13 earnings per share. On average, analysts expect that Chemours will post 1.07 EPS for the current fiscal year.
Chemours Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Sunday, May 17th were given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend was Friday, May 15th. Chemours’s dividend payout ratio is presently -13.26%.
About Chemours
Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.
Chemours’ principal business activities are organized into three core segments.
Featured Articles
- Five stocks we like better than Chemours
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.
